The levels of ERK and Akt activation in mutant BRAF colon cancer cells at 24 and 36 hours after treatment were comparable to the basal levels observed in the cells before treatment (Figure 2A and 2B). The gene discussed is AKT1; the disease is colonic neoplasm.